- Wealth
- ₹1,900 Cr
- Company
- Privi Speciality Chemicals
About Bhaktavatsala Rao Doppalapudi
Data last updated:
Bhaktavatsala Rao Doppalapudi is a Whole-Time Director at Privi Speciality Chemicals Limited (since 2017), Director at Vivira Investment And Trading Private Limited (since 1990) and Managing Director at Privi Biotechnologies Private Limited (since 2011), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Financial Services and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹2,141 Cr; the largest is Privi Speciality Chemicals Limited at ₹2,122 Cr (FY 2025). Earlier, Bhaktavatsala Rao Doppalapudi was a Director at Privi Life Sciences Private Limited (2008–2009) and Director at Privi Organics Limited (1982–2020) and 3 more.
Doppalapudi Bhaktavatsala Rao and family are #1,233 among India's richest people (2026), with wealth of ₹1,900 Cr.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 11 May 2017 | 1985 | ₹2,122 Cr (FY 2025) | Active | |
| Director | 19 Feb 1990 | 1990 | ₹13.40 Cr (FY 2023) | Active | |
| Managing Director | 06 Aug 2011 | 1985 | ₹6.15 Cr (FY 2025) | Active | |
| Director | 17 Aug 2012 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Sep 2008 | 1990 | ₹105 Cr (FY 2025) | Active | |
| Director | 05 Apr 1982 | 1982 | ₹6.33 Cr (FY 2022) | Amalgamated | |
| Managing Director | 14 Dec 2009 | 2009 | ₹99.09 Cr (FY 2024) | Amalgamated | |
| Director | 12 Apr 2004 | 1994 | ₹16.5 Lakh (FY 2020) | Amalgamated | |
| Whole-Time Director | 22 Feb 2017 | 2016 | ₹1,097 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhaktavatsala Rao Doppalapudi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhaktavatsala Rao Doppalapudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhaktavatsala Rao Doppalapudi
Bhaktavatsala Rao Doppalapudi currently holds 4 directorships: Privi Speciality Chemicals Limited (Whole-Time Director, since 11 May 2017, revenue ₹2,122 Cr (FY 2025)); Vivira Investment And Trading Private Limited (Director, since 19 Feb 1990, revenue ₹13.40 Cr (FY 2023)); Privi Biotechnologies Private Limited (Managing Director, since 06 Aug 2011, revenue ₹6.15 Cr (FY 2025)); Satellite Technologies Private Limited (Director, since 17 Aug 2012).
Bhaktavatsala Rao Doppalapudi was first appointed on 05 Apr 1982 as Director at Privi Organics Limited. The most recent appointment on record is 11 May 2017 at Privi Speciality Chemicals Limited.
The 3 current companies of Bhaktavatsala Rao Doppalapudi that report revenue have a combined latest revenue of ₹2,141 Cr: Privi Speciality Chemicals Limited ₹2,122 Cr (FY 2025); Vivira Investment And Trading Private Limited ₹13.40 Cr (FY 2023); Privi Biotechnologies Private Limited ₹6.15 Cr (FY 2025).
Bhaktavatsala Rao Doppalapudi held 5 earlier board appointments: Privi Life Sciences Private Limited (Director, 02 Sep 2008 to 26 Sep 2009); Privi Organics Limited (Director, 05 Apr 1982 to 03 Jan 2020); Privi Life Sciences Private Limited (Managing Director, from 14 Dec 2009); Minar Organics P Ltd (Director, from 12 Apr 2004); Privi Organics India Limited (Whole-Time Director, from 22 Feb 2017).
The current boards of Bhaktavatsala Rao Doppalapudi's companies include Anurag Surana (Privi Speciality Chemicals Limited), Ashwini Saumil Shah (Privi Speciality Chemicals Limited), Hemang Manhar Gandhi (Privi Speciality Chemicals Limited), Mahesh Purshottam Babani (Privi Speciality Chemicals Limited), Narayan Sreenivasan Iyer (Privi Speciality Chemicals Limited), Naresh Madhu Tejwani (Privi Speciality Chemicals Limited), among others.